Trial intelligence / Profile preview

EARLY-MYO-PE: Mechanical Thrombectomy vs Thrombolysis for Acute PE

NCT07032025Phase 1Not yet recruiting

Sponsor
Renji Hospital
Start
Jul 2025
Primary completion
Jul 2027
01

Overview

Phase 1, randomised, open-label trial in pulmonary embolism (PE) (2 arms), sponsored by Renji Hospital. Primary endpoints: Absolute reduction in Right Ventricular/Left Ventricular diameter ratio at 48 hours and Incidence of Major Adverse Events (MAEs) at 48 hours. Planned start Jul 2025; status: not yet recruiting.

02

Conditions

pulmonary embolism (PE)

Beyond the preview

Go deeper on NCT07032025.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07032025.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call